Answers are grounded in this paper and cite their sources.
challenge. The iVAX platform promises to accelerate development of new conjugate vaccines with increased access through refrigeration-independent distribution and portable production.
No takes yet. Share an insight, caveat, or question.
Stark et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: